BioMarin: Genzyme virus problem won

proklofuxaanygez.blogspot.com
Genzyme (NASDAQ: GENZ) found a virus strain and stoppe production of two drugs atthe Mass., facility. The strain, Vesivirus 2117, apparentlty does not cause human infection but interruptws the growth of cells that are used tomake drugs. Aldurazymee — a treatment for MPS I, a rare and fatalk disease caused by an enzymsdeficiency — was last fille at the Genzyme facility in September 2008, according to BioMarin (NASDAQ: BMRN). The company has about 10 monthas of vialed inventoryon hand, it and uses a second fill finish A third supplier is expected to be qualified later this year, BioMarimn said. BioMarin makes the bulk material used in Aldurazymre at itsNovato facility.
The Food and Drug Administration hadinspected Genzyme’s plan in September and October and reportedly was concerned about controls to protect against contamination.